Protective effects of baicalein against rotenone-induced neurotoxicity in PC12 cells and isolated rat brain mitochondria

European Journal of Pharmacology

Volumn 674, Issue 2-3, 2012, Pages 227-233

  Li, Xiao Xiu ^a   He, Guo Rong ^a   Mu, Xin ^a   Xu, Bei ^a   Tian, Shuo ^a   Yu, Xin ^a   Meng, Fan Rui ^a   Xuan, Zhao Hong ^a   Du, Guan Hua ^a  

^a INSTITUTE OF MATERIA MEDICA   (China)

Author keywords

Baicalein; Mitochondrial dysfunction; Oxidative stress; Parkinson's disease; Rotenone

Indexed keywords

ADENOSINE TRIPHOSPHATE; BAICALEIN; CASPASE 3; CASPASE 7; REACTIVE OXYGEN METABOLITE; ROTENONE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; BIOACCUMULATION; BRAIN MITOCHONDRION; CELL ISOLATION; CELL STRAIN; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; DRUG STRUCTURE; DRUG TARGETING; ENZYME ACTIVATION; IN VIVO STUDY; MALE; MITOCHONDRIAL MEMBRANE POTENTIAL; MITOCHONDRIAL RESPIRATION; MITOCHONDRION SWELLING; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; APOPTOSIS; BRAIN; CASPASE 3; CASPASE 7; CELL RESPIRATION; CYTOPROTECTION; FLAVANONES; MALE; MEMBRANE POTENTIAL, MITOCHONDRIAL; MITOCHONDRIA; MITOCHONDRIAL SWELLING; NEUROPROTECTIVE AGENTS; NEUROTOXINS; OXIDATIVE STRESS; PC12 CELLS; RATS; RATS, SPRAGUE-DAWLEY; ROTENONE;

EID: 84855525812     PISSN: 00142999     EISSN: 18790712     Source Type: Journal    
DOI: 10.1016/j.ejphar.2011.09.181     Document Type: Article

References (30)

1. Abele, D., Heise, K., Portner, H.O., Puntarulo, S., 2002. Temperature-dependence of mitochondrial function and production of reactive oxygen species in the intertidal mud clam Mya arenaria. J. Exp. Biol. 205, 1831-1841. (Pubitemid 34853435)
2. Betarbet, R., Sherer, T.B., MacKenzie, G., Garcia-Osuna, M., Panov, A.V., Greenamyre, J.T., 2000. Chronic systemic pesticide exposure reproduces features of Parkinson's disease. Nat. Neurosci. 3, 1301-1306.
3. Bonuccelli, U., Del, D.P., 2006. New pharmacologic horizons in the treatment of Parkinson disease. Neurology 67, S30-S38. (Pubitemid 44568832)
4. Chen, Y.C., Chow, J.M., Lin, C.W., Wu, C.Y., Shen, S.C., 2006. Baicalein inhibition of oxidative-stress-induced apoptosis via modulation of ERKs activation and induction of HO-1 gene expression in rat glioma cells C6. Toxicol. Appl. Pharmacol. 216, 263-273.
5. Cheng, Y., He, G., Mu, X., Zhang, T., Li, X., Hu, J., Xu, B., Du, G., 2008. Neuroprotective effect of baicalein against MPTP neurotoxicity: behavioral, biochemical and immunohisto-chemical profile. Neurosci. Lett. 441, 16-20.
6. Ciesielska, E., Gwardys, A., Metodiewa, D., 2002. Anticancer, antiradical and antioxidative actions of novel Antoksyd S and its major components, baicalin and baicalein. Anticancer. Res. 22, 2885-2891.
7. Dukes, A.A., Korwek, K.M., Hastings, T.G., 2005. The effect of endogenous dopamine in rotenone-induced toxicity in PC12 cells. Antioxid. Redox Signal. 7, 630-638. (Pubitemid 40563201)
8. Freestone, P.S., Chung, K.K., Guatteo, E.,Mercuri, N.B., Nicholson, L.F., Lipski, J., 2009. Acute action of rotenone on nigral dopaminergic neurons-involvement of reactive oxygen species and disruption of Ca2+ homeostasis. Eur. J. Neurosci. 30, 1849-1859.
9. Greenamyre, J.T., Betarbet, R., Sherer, T.B., 2003. The rotenonemodel of Parkinson's disease: genes, environment and mitochondria. Parkinsonism Relat. Disord. 9 (Suppl. 2), S59-S64. (Pubitemid 36952523)
10. Hatcher, J.M., Pennell, K.D., Miller, G.W., 2008. Parkinson's disease and pesticides: a toxicological perspective. Trends Pharmacol. Sci. 29, 322-329.
11. Hu, L.F., Lu, M., Wu, Z.Y., Wong, P.T., Bian, J.S., 2009. Hydrogen sulfide inhibits rotenone-induced apoptosis via preservation of mitochondrial function. Mol. Pharmacol. 75, 27-34.
12. Isenberg, J.S., Klaunig, J.E., 2000. Role of themitochondrialmembrane permeability transition (MPT) in rotenone-induced apoptosis in liver cells. Toxicol. Sci. 53, 340-351. (Pubitemid 30100151)
13. Kim,H.J., Park,H.J., Park,H.K., Chung, J.H., 2009. Tranexamic acid protects against rotenone-induced apoptosis in human neuroblastoma SH-SY5Y cells. Toxicology 262, 171-174.
14. Langston, J.W., Ballard, P., Tetrud, J.W., Irwin, I., 1983. Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis. Science 219, 979-980 (80-).
15. Lee, H.J., Noh, Y.H., Lee, D.Y., Kim, Y.S., Kim, K.Y., Chung, Y.H., Lee, W.B., Kim, S.S., 2005. Baicalein attenuates 6-hydroxydopamine-induced neurotoxicity in SH-SY5Y cells. Eur. J. Cell Biol. 84, 897-905. (Pubitemid 41574433)
16. Li, N., Ragheb, K., Lawler, G., Sturgis, J., Rajwa, B., Melendez, J.A., Robinson, J.P., 2003. Mitochondrial complex I inhibitor rotenone induces apoptosis through enhancing mitochondrial reactive oxygen species production. J. Biol. Chem. 278, 8516-8525. (Pubitemid 36800604)
17. Li-Weber, M., 2009. New therapeutic aspects of flavones: the anticancer properties of Scutellaria and its main active constituents Wogonin, Baicalein and Baicalin. Cancer Treat. Rev. 35, 57-68.
18. Mu, X., He, G., Cheng, Y., Li, X., Xu, B., Du, G., 2009. Baicalein exerts neuroprotective effects in 6-hydroxydopamine-induced experimental parkinsonism in vivo and in vitro. Pharmacol. Biochem. Behav. 92, 642-648.
19. Mu, X., He, G.R., Yuan, X., Li, X.X., Du, G.H., 2011. Baicalein protects the brain against neuron impairments induced by MPTP in C57BL/6 mice. Pharmacol. Biochem. Behav. 98 (2), 286-291.
20. Panov, A., Dikalov, S., Shalbuyeva, N., Taylor, G., Sherer, T., Greenamyre, J.T., 2005. Rotenone model of Parkinson disease: multiple brain mitochondria dysfunctions after short term systemic rotenone intoxication. J. Biol. Chem. 280, 42026-42035. (Pubitemid 43023171)
21. Perez, C.A., Wei, Y., Guo, M., 2009. Iron-binding and anti-Fenton properties of baicalein and baicalin. J. Inorg. Biochem. 103, 326-332.
22. Przedborski, S., Tieu, K., Perier, C., Vila, M., 2004. MPTP as a mitochondrial neurotoxic model of Parkinson's disease. J. Bioenerg. Biomembr. 36, 375-379. (Pubitemid 39619844)
23. Schapira, A.H., 2008. Mitochondria in the aetiology and pathogenesis of Parkinson's disease. Lancet Neurol. 7, 97-109. (Pubitemid 350251942)
24. Sherer, T.B., Kim, J.H., Betarbet, R., Greenamyre, J.T., 2003. Subcutaneous rotenone exposure causes highly selective dopaminergic degeneration and alpha-synuclein aggregation. Exp. Neurol. 179, 9-16. (Pubitemid 36062614)
25. Simon, N., Papa, K., Vidal, J., Boulamery, A., Bruguerolle, B., 2003. Circadian rhythms of oxidative phosphorylation: effects of rotenone and melatonin on isolated rat brain mitochondria. Chronobiol. Int. 20, 451-461. (Pubitemid 36828478)
26. Szeto, H.H., 2006. Mitochondria-targeted peptide antioxidants: novel neuroprotective agents. AAPS J. 8, E521-E531.
27. Tan, Q.R., Wang, X.Z., Wang, C.Y., Liu, X.J., Chen, Y.C., Wang, H.H., Zhang, R.G., Zhen, X.C., Tong, Y., Zhang, Z.J., 2007. Differential effects of classical and atypical antipsychotic drugs on rotenone-induced neurotoxicity in PC12 cells. Eur. Neuropsychopharmacol. 17, 768-773. (Pubitemid 47588861)
28. Tatton, W.G., Olanow, C.W., 1999. Apoptosis in neurodegenerative diseases: the role of mitochondria. Biochim. Biophys. Acta Bioenerg. 1410, 195-213. (Pubitemid 29078605)
29. Wang, N., Li, D., Lu, N.H., Yi, L., Huang, X.W., Gao, Z.H., 2010. Peroxynitrite and hemoglobin-mediated nitrative/oxidative modification of human plasma protein: effects of some flavonoids. J. Asian Nat. Prod. Res. 12, 257-264.
30. Xu, Y.W., Sun, L., Liang, H., Sun, G.M., Cheng, Y., 2010. 12/15-Lipoxygenase inhibitor baicalein suppresses PPAR gamma expression and nuclear translocation induced by cerebral ischemia/reperfusion. Brain Res. 1307, 149-157.